A P2 and P3 substrate specificity comparison between the Murray Valley encephalitis and West Nile virus NS2B/NS3 protease using C-terminal agmatine dipeptides

Peptides

Volumn 52, Issue , 2014, Pages 49-52

  Ang, Melgious Jin Yan ^a   Li, Zhitao ^a   Lim, Huichang Annie ^a   Ng, Fui Mee ^a   Then, Siew Wen ^a   Wee, John Liang Kuan ^a   Joy, Joma ^a   Hill, Jeffrey ^a   Chia, C S Brian ^a  

^a Agency for Science   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AGMATINE; ARGININE; MONTIRELIN; PEPTIDOMIMETIC AGENT; POLYPROTEIN; PROTEINASE; SERINE PROTEINASE;

ARTICLE; CONTROLLED STUDY; ENZYME SPECIFICITY; FATALITY; HUMAN; MURRAY VALLEY ENCEPHALITIS; MURRAY VALLEY ENCEPHALITIS VIRUS; PAPUA NEW GUINEA; PRIORITY JOURNAL; VIRUS PURIFICATION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS;

AGMATINE; DIPEPTIDES; ENCEPHALITIS VIRUS, MURRAY VALLEY; RNA HELICASES; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; VIRAL NONSTRUCTURAL PROTEINS; WEST NILE VIRUS;

EID: 84891613371     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.12.002     Document Type: Article

References (22)

1. M.J.Y. Ang, H.A. Lim, and C.S.B. Chia Solid-phase synthesis of a library of C-terminal agmatine dipeptides using a backbone amide linker (BAL) strategy Tetrahedron Lett 53 2012 5511 5514
2. R. Assenberg, E. Mastrangelo, T.S. Walter, A. Verma, M. Milani, and R.J. Owens et al. Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication J Virol 83 2009 12895 12906
3. D.W.C. Beasly, A.D.T. Barrett, and R.B. Tesh Resurgence of West Nile neurologic disease in the United States in 2012: what happened? Antiviral Res 99 2013 1 5
4. A. Brown, S. Bolisetty, P. Whelan, D. Smith, and G. Wheaton Reappearance of human cases due to Murray Valley encephalitis virus and Kunjin virus in Central Australia after an absence of 26 years Commun Dis Intell 26 2002 39 44
5. K.J. Chappell, M.J. Stoermer, D.P. Fairlie, and P.R. Young Insights to substrate binding and processing by West Nile virus NS3 protease through combined modeling, protease mutagenesis and kinetic studies J Biol Chem 281 2006 38448 38458 (Pubitemid 46041968)
6. K.J. Chappell, M.J. Stoermer, D.P. Fairlie, and P.R. Young West Nile virus NS2B/NS3 protease as an antiviral target Curr Med Chem 281 2008 2771 2784
7. L. Dalgarno, D.W. Trent, J.H. Strauss, and C.M. Rice Partial nucleotide sequence of the Murray Valley encephalitis virus genome J Mol Biol 187 1986 309 323
8. M.S. Diamond Progress on the development of therapeutics against West Nile virus Antiviral Res 83 2009 214 227
9. E.L. French Murray Valley encephalitis: isolation and characterization of the aetiological agent Med J Aust 1 1952 100 103
10. D. Ghosh, and A. Basu Present perspectives on flaviviral chemotherapy Drug Discov Today 13 2008 619 624
11. J. Joy, F.M. Ng, L.K. Wee, Z.P. Kwek, S.W. Then, and J. Hill Biochemical characterization of the Murray Valley encephalitis virus proteinase FEBS Lett 584 2010 3149 3152
12. J. Knox, R.U. Cowan, J.S. Doyle, M.K. Ligtermoet, J.S. Archer, and J.N. Burrow et al. Murray Valley encephalitis: a review of clinical features, diagnosis and treatment Med J Aust 196 2012 1 5
13. H.A. Lim, J. Joy, J. Hill, and C.S.B. Chia Novel agmatine and agmatine-like peptidomimetic inhibitors of the West Nile virus NS2B/NS3 serine protease Eur J Med Chem 46 2011 3130 3134
14. K. Löhr, J.E. Knox, W.Y. Phong, N.L. Ma, Z. Yin, and A. Sampath et al. Yellow Fever virus NS3 protease: peptide-inhibition studies J Gen Virol 88 2007 2223 2227 (Pubitemid 47194219)
15. J.S. Mackenzie, and A.K. Broom Australian X disease, Murray Valley encephalitis and the French connection Vet Microbiol 46 1995 79 90
16. J.S. Mackenzie, D.J. Gubler, and L.R. Petersen Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and Dengue viruses Nat Med 10 2004 S98 S109
17. A. Opar Excitement grows for potential revolution in hepatitis C virus treatment Nat Rev Drug Discov 9 2010 501 503
18. I. Schechter, and A. Berger On the size of active sites in proteases. I. Papain Biochem Biophys Res Commun 27 1967 157 162
19. K.C. Smithburn, T.P. Hughes, A.W. Burke, and J.H. Paul A neurotropic virus isolated from the blood of a native of Uganda Am J Trop Med 20 1940 471 492
20. M.J. Stoermer, K.J. Chappell, S. Liebscher, C.M. Jensen, C.H. Gan, and P.K. Gupta et al. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity J Med Chem 51 2008 5714 5721
21. S. Venkatraman Discovery of Boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections Trends Pharmacol Sci 33 2012 289 294
22. Z. Yin, S.J. Patel, W.L. Wang, W.L. Chan, K.R.R. Rao, and G. Wang et al. Peptide inhibitors of the Dengue virus NS3 protease Bioorg Med Chem Lett 16 2006 40 43